High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma

References

• ChenJGZhuJZhangYHCancer survival in Qidong between 1972 and 2011: a population-based analysisMol Clin Oncol20176694495428588795
   PubMedGoogle Scholar
• FinnRSZhuAXFarahWTherapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: a systematic review and meta-analysisHepatology201867142243528881497
   PubMed Web of Science ®Google Scholar
• YaoDJiangDHuangZAbnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinomaCancer200088476176910679644
   PubMed Web of Science ®Google Scholar
• ZhengWYaoMQianQOncogenic secretory clusterin in hepatocellular carcinoma: expression at early staging and emerging molecular targetOncotarget2017832523215233228881732
   PubMedGoogle Scholar
• YanXDYaoMWangLOverexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformationWorld J Gastroenterol201319366084609224106410
   PubMed Web of Science ®Google Scholar
• QianJYaoDDongZCharacteristics of hepatic IGF-II expression and monitored levels of circulating IGF-II mRNA in metastasis of hepatocellular carcinomaAm J Clin Pathol2010134579980620959664
   PubMed Web of Science ®Google Scholar
• ReevesRHigh mobility group (HMG) proteins: modulators of chromatin structure and DNA repair in mammalian cellsDNA Repair20153612213626411874
   PubMed Web of Science ®Google Scholar
• StrosMHMGB proteins: interactions with DNA and chromatinBiochim Biophys Acta201017991–210111320123072
   PubMed Web of Science ®Google Scholar
• GerlitzGHMGNs, DNA repair and cancerBiochim Biophys Acta201017991–2808520004154
   PubMed Web of Science ®Google Scholar
• ChenSDongZYangPHepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasisCancer Lett2017394223228216372
   PubMed Web of Science ®Google Scholar
• ZhangDCaoJZhongQLong noncoding RNA PCAT-1 promotes invasion and metastasis via the miR-129-5p-HMGB1 signaling pathway in hepatocellular carcinomaBiomed Pharmacother2017951187119328931210
   PubMed Web of Science ®Google Scholar
• TohmeSYazdaniHOLiuYHypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interactionHepatology201766118219728370295
   PubMed Web of Science ®Google Scholar
• ZhengWJYaoMFangMWangLDongZZYaoDFAbnormal expression of HMGB-3 is significantly associated with malignant transformation of hepatocytesWorld J Gastroenterol201824323650366230166860
   PubMed Web of Science ®Google Scholar
• Ministry of Health of the People’s Republic of ChinaUpdated standards for the diagnosis and treatment of primary liver cancerZhonghua Gan Zang Bing Za Zhi2012206419426 Chinese [with English abstract]23230592
   PubMedGoogle Scholar
• OYManagement of clinical diagnosis, and antiviral therapy for HBV-related cirrhosisZhonghua Gan Zang Bing Za Zhi201422532733525222972
   PubMedGoogle Scholar
• SpechtEKaemmererDSängerJComparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasmsHistopathology201567336837725641082
   PubMed Web of Science ®Google Scholar
• YanaiHBanTTaniguchiTHigh-mobility group box family of proteins: ligand and sensor for innate immunityTrends Immunol2012331263364023116548
   PubMed Web of Science ®Google Scholar
• KwonJHKimJParkJYOverexpression of high-mobility group box 2 is associated with tumor aggressiveness and prognosis of hepatocellular carcinomaClin Cancer Res201016225511552120851854
   PubMed Web of Science ®Google Scholar
• WangLYaoMDongZZhangYYaoDCirculating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoringTumour Biol201435192024006223
   PubMedGoogle Scholar
• RoskillyARoweIASurveillance for hepatocellular cancerClin Med201818Suppl 2s66s69
   PubMed Web of Science ®Google Scholar
• MasudaKOnoAAikataHSerum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapyJ Gastroenterol201853110711828474222
   PubMed Web of Science ®Google Scholar
• SadeghiMLahdouIOweiraHSerum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinomaBr J Cancer2015113575676226270232
   PubMed Web of Science ®Google Scholar
• TangHRLuoXQXuGHigh mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinomaWorld J Gastroenterol201218487319732623326140
   PubMed Web of Science ®Google Scholar
• SongNLiuBWuJLPrognostic value of HMGB3 expression in patients with non-small cell lung cancerTumour Biol20133452599260323609034
   PubMedGoogle Scholar
• GaoJZouZGaoJIncreased expression of HMGB3: a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinomaInt J Clin Exp Pathol20158134535225755721
   PubMed Web of Science ®Google Scholar
• LiMCaiYZhaoHOverexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patientsTumour Biol20153664785479225647262
   PubMedGoogle Scholar
• GuoSWangYGaoYKnockdown of high mobility group-box 3 (HMGB3) expression inhibits proliferation, reduces migration, and affects chemosensitivity in gastric cancer cellsMed Sci Monit2016223951396027774979
   PubMed Web of Science ®Google Scholar
• ZhangZChangYZhangJHMGB3 promotes growth and migration in colorectal cancer by regulating WNT/β-catenin pathwayPLoS One2017127e017974128678825
   PubMed Web of Science ®Google Scholar
• LiXWuYLiuATangXMiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3Biochem Biophys Res Commun2016477476877327363334
   PubMed Web of Science ®Google Scholar
• FujiwaraNFriedmanSLGoossensNHoshidaYRisk factors and prevention of hepatocellular carcinoma in the era of precision medicineJ Hepatol201868352654928989095
   PubMed Web of Science ®Google Scholar